RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping.

Guilherme Afonso VergaraGisele Cristine EugenioSuzana Maria Fleury MalheirosElivane da Silva VictorRicardo Weinlich

Published in: Journal of neuro-oncology (2020)

RIPK3 expression levels can be used in combination with IDH mutational status to better subgroup LGG patients regarding overall survival.

Keyphrases